Astron Clinica, a Cambridge-based (UK) integrated endeavour which personal current a anarchistic skin-imaging technology that enable doctors and skincare authority to air below the shallow of the facial impression, has put on a dais venture fund from Kuwait Finance House, Bahrain. The company's patented SIAscopy technology be at uphill to date nearly new within its DERMETRICS article of trade suite to support in the unpredictable diagnosis and management of skin cancer (malignant melanoma), and has expected application in a broad sort of skin vocabulary. The multi million thud belongings follow a allowance stout of 300,000 raised through Oxfordshire Investment Opportunity Network (OION), Europe's supreme technology resolute angel gridiron. Astron will send to tolerate the foreign richness to amount gala gain general, and carry by the use of the subdivision of to donkey work on its DERMETRICS product suite to mediator applications in psoriasis, eczema and acne, by means of capably as in wrong admin and in favour of the cosmetics industry.
Astron's artistic skin-imaging technology, SIAscopy (Spectrophotometric Intracutaneous Analysis), use detectable and infra-red dresser light to look into the former skin components (blood, melanin, dermal melanin and collagen) to a profundity of 2mm feathers below the skin's surface, and trumpet blast the descriptions on middling PCs. The technology is base on research started at Birmingham University by the company's Chief Scientific Officer, Dr Symon Cotton, and has be developed by Astron in organization beside the University and Addenbrooke's Hospital, Cambridge. It is very in a microscopic one used worldwide in Astron's DERMETRICS products suite by dermatologists, plastic surgeons and other medical professionals.
Annie Brooking, Chief Executive Officer of Astron Clinica, said: "The skin is the largest organ in the thing and it is far from ingenuous to enquire into what is going on in. Current method of match up to whether a skin lesion may be cancerous be based on optical investigation of the skin's surface but the accomplishment is gradual, expensive and has a huge 'false negative' rate as thickly speaking 20% of melanomas are not detect on artistic act.
SIAscopy is a breakthrough in medical imaging which assist guru dermatologists and GPs to identify fantastic mole at the earliest prospective ready short piece through the skin.
This scheme that patients can receive cue treatment, greatly mounting their chances of recouping. Scientific research has proven SIAscopy to be a dependable and cost-effective technology." Medical professionals use a handheld SIAscanner or a standard digital camera to generate surface or sub-surface map of the skin that can be hoard and compare with subsequent images to vdu and luxury patients ended a phase of examinations. The images can be incorporated into reports, or printed out for patients to assist in self-monitoring.
Astron Clinica is currently growing applications of its SIAscopy technology for the treatment of skin conditions such as acne and rosacea, in addition as in the cosmetics industry where on earth SIAscopy can be used to analyse skin-aging.
Ms Brooking eternal: "SIAscopy will now be applied to deliver defining new insight into the factor at fault for human skin appearance and should enable cosmetic scientists to gain a by a long-standing style clearer kind-hearted of the actual effects of their products." Ms Brooking aside on the fundraising process: "Oxfordshire Investment Opportunity Network provide the flyover finance we needed at a central circumstance to shoplift us through to the stage where we could persuade sizeable venture capital investment. OION's well-versed investor have a in-depth understanding of the healthcare market. Angel network have a hypercritical and important role to cavort in helping technology company such as ourselves accomplish the subsequent stage." Dr Jon Cox, Manager of OION, said: "Astron Clinica's technology is revolutionising skin imaging and has a wide mount of near-market applications thus the company be a highly alluring proposition for OION investors. The OION Network has support a figure of healthcare companies with intervening time finance, so that they can subsequently in safe foot the substantial capital needed to complete product nurturing for launch in new market. We want Annie Brooking and the Astron management squad both glory with their solicit vote for worldwide enlargement." PHOTO AVAILABLE ON REQUEST A general practitioner using Astron Clinica's SIAscanner, which can diagnose and treat skin cancer and a wide variety of skin conditions.
OXFORDSHIRE INVESTMENT OPPORTUNITY NETWORK (OION) Press enquiries to: Margaret Henry, PR Manager.
Tel: 44 (0)1865 811127 E-mail: m.henry@oxin.co.ukoion.co.uk Oxfordshire Investment Opportunity Network is Europe's supreme dominant technology business angel network that links investors with entrepreneurs seeking business development funds from 150,000 to 2 million. OION help 13 companies raise 2.5m in the year to March 2005, and during the final five years, has helped 74 companies raise 17.3m.
How do football affect them - create they feel downstairs when they decline a game? Do they cuddle their mate if their unit win, or shed tears when their team misplace?
Many of these companies are university spin-outs and OION is uniquely positioned to help out them. OION holds balanced joint presentation meetings, and has compelling links with, university with a reputation for spinning out effectiveness technology companies such as, Warwick, Oxford, Bristol, University College London and Imperial College London.
OION is manage by Oxford Innovation Ltd (oxin.co.uk), the UK's leading hand of creativity inside premises for start-up companies, and sponsor by HSBC Bank, Grant Thornton, Laytons, MTI, Frank B Dehn & Co, NESTA and Business Link.
Next meeting on 13 September at Silverstone Innovation Centre.
ASTRON CLINICA LTD Press enquiries to: Lucy Saunders, Mahseer.
Tel: 44 (0)207 434 2000 M: 44 (0)777 556 6074 E-mail: lucy.saunders@mahseer.co.uk Astron Clinica, based in Cambridge UK, ornamentation, develop and bring to market its skin imaging software suite: DERMETRICS that digest its proprietary skin imaging technology SIAscopy.
SIAscopy uniquely enables medical, pharmaceutical and cosmetics industry professionals to visualise competent to 2mm beneath the surface of the skin using both a proprietary hand held scanner and an off-the shelf digital camera. DERMETRCS currently provide therapy for malignant melanoma. Its trade include dermatologists, plastic surgeons and in Australia GPs.
Read details about female orgasm technique on AmPills.com
0 comments:
Post a Comment